News

Under the terms of the transaction, Stiefel will utilize Allergan’s proprietary technology and tazarotene in several ways. Stiefel will co-promote Allergan’s Tazorac (tazarotene) to dermatologists in the US.

This large, prospective evaluation of haptoglobin (Hp) typing demonstrates how 40% of diabetic patients can achieve significant cardiovascular benefit from tight glycemic control. The results of a prospective

Mundinter’s agreement calls for minimum sales of 300k units the first year, 600k units the second, 1.0mm units the third, 1.1mm the fourth and minimum of 1.2mm units

This clinical trial is a 12-day, single-center, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of CRx-191 in reducing psoriatic infiltrate band thickness in subjects with plaque

Transgenomic’s European sales and support organization will market, sell and service the instruments. BioView’s products include the Duet, Allegro and Accord automated workstations for the scanning and classification

Immunization with Sanofi Pasteur’s tetravalent dengue candidate vaccine generated a sero-neutralizing antibody response against all four serotypes of the virus responsible for dengue fever in 100% of adults

Under the terms of the collaboration agreement and related stock purchase agreement, GTx and Merck will combine their respective selective androgen receptor modulators (SARM) research programs. GTx will

The Phase II/III early-stage and late-stage retinitis pigmentosa (RP) are randomized, multi-centered, double-masked, sham-controlled studies evaluating NT-501 in 60 subjects with early-stage and late-stage RP, respectively. Visual field

RPL554 is a long-acting bronchodilator or anti-inflammatory molecule being developed to treat hay fever (rhinitis), asthma and chronic obstructive pulmonary disease. The inhalation studies will be undertaken by